Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    GTHR Net Margin

    As of 2025-07-05, the Net Margin of GeneThera Inc (GTHR) is -19900%.

    Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.

    GTHR Net Margin - Historical Value
    DateValue
    2021-12-31 -19900%
    2020-12-31 -
    2019-12-31 -
    2018-12-31 -
    2017-12-31 -
    2016-12-31 -
    2015-12-31 -
    2014-12-31 -
    2013-12-31 -
    2012-12-31 -
    GTHR Net Margin - Peers Comparison
    TickerNameValue
    ALSEAlseres Pharmaceuticals Inc-198.7%
    ATRXAdhera Therapeutics Inc-4753.2%
    AVXTAVAX Technologies Inc-1039.5%
    BSTGBiostage Inc-14120.7%
    BSYIBiosyntech Inc-31561%
    CGNHCardioGenics Holdings Inc-100619.2%
    CLCSCell Source Inc-
    CNSTConstellation Pharmaceuticals Inc-
    CRXMGene Biotherapeutics Inc-8163.3%
    CYTHCyclo Therapeutics Inc-1863.4%
    EPRSQEPIRUS Biopharmaceuticals Inc-7444.8%
    FWPForward Pharma A/S73.4%
    GBIMGlobeimmune Inc-42.8%
    HCYTH-Cyte Inc-2271.3%
    IMNPQImmune Pharmaceuticals Inc-1177500%
    IMUNImmune Therapeutics Inc-7202.8%
    LBL.VLattice Biologics Ltd-60.2%
    MCETMulticell Technologies Inc-770.6%
    MYMXMymetics Corp-467.4%
    PHIOPhio Pharmaceuticals Corp-44550%
    PKPHPeak Pharmaceuticals Inc-
    PLXProtalix Biotherapeutics Inc5.5%
    PZRXQPZ Wind Down Inc-1967.2%
    RASPRasna Therapeutics Inc-
    RCHARich Pharmaceuticals Inc-1471.6%
    RGBOQRegen Biologics Inc-724.2%
    SGBISangui Biotech International Inc-85.7%
    VBIXViewbix Inc-975%
    Tickers added to watchlist